{"id":2778,"date":"2025-12-16T10:12:48","date_gmt":"2025-12-16T09:12:48","guid":{"rendered":"https:\/\/fonds-mss.fr\/?p=2778"},"modified":"2025-12-16T10:31:08","modified_gmt":"2025-12-16T09:31:08","slug":"le-fonds-de-dotation-mutualiste-pour-la-sante-et-la-solidarite-rejoint-le-fonds-invincible-ete-pour-accelerer-la-recherche-sur-la-maladie-de-charcot","status":"publish","type":"post","link":"https:\/\/fonds-mss.fr\/index.php\/2025\/12\/16\/le-fonds-de-dotation-mutualiste-pour-la-sante-et-la-solidarite-rejoint-le-fonds-invincible-ete-pour-accelerer-la-recherche-sur-la-maladie-de-charcot\/","title":{"rendered":"Le Fonds de dotation mutualiste pour la sant\u00e9 et la solidarit\u00e9 rejoint le Fonds Invincible \u00c9t\u00e9 pour acc\u00e9l\u00e9rer la recherche sur la maladie de Charcot"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2778\" class=\"elementor elementor-2778\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-af89cc8 e-flex e-con-boxed e-con e-parent\" data-id=\"af89cc8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-0dcc232 elementor-widget elementor-widget-image\" data-id=\"0dcc232\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/fonds-mss.fr\/wp-content\/uploads\/2025\/12\/investissement-solidaire-1024x683.png\" class=\"attachment-large size-large wp-image-2779\" alt=\"\" srcset=\"https:\/\/fonds-mss.fr\/wp-content\/uploads\/2025\/12\/investissement-solidaire-1024x683.png 1024w, https:\/\/fonds-mss.fr\/wp-content\/uploads\/2025\/12\/investissement-solidaire-300x200.png 300w, https:\/\/fonds-mss.fr\/wp-content\/uploads\/2025\/12\/investissement-solidaire-768x512.png 768w, https:\/\/fonds-mss.fr\/wp-content\/uploads\/2025\/12\/investissement-solidaire.png 1536w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a94a9d0 e-flex e-con-boxed e-con e-parent\" data-id=\"a94a9d0\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c6e9015 elementor-widget elementor-widget-text-editor\" data-id=\"c6e9015\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Le Fonds de dotation mutualiste pour la sant\u00e9 et la solidarit\u00e9 a le plaisir d\u2019annoncer sa souscription au Fonds Invincible \u00c9t\u00e9, un fonds innovant cr\u00e9\u00e9 pour soutenir la recherche sur la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), plus connue sous le nom de maladie de Charcot.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-9a43460 e-flex e-con-boxed e-con e-parent\" data-id=\"9a43460\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a53b717 elementor-widget elementor-widget-text-editor\" data-id=\"a53b717\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Port\u00e9 par Olivier Goy, ambassadeur de l\u2019Institut du cerveau et lui-m\u00eame atteint de la maladie, le Fonds Invincible \u00c9t\u00e9 est g\u00e9r\u00e9 pro bono (pour le bien public) par la soci\u00e9t\u00e9 PAMS (groupe 123 Investment Managers). Ce fonds professionnel sp\u00e9cialis\u00e9 investit dans l\u2019\u00e9conomie r\u00e9elle, aupr\u00e8s d\u2019entreprises fran\u00e7aises et europ\u00e9ennes, avec une strat\u00e9gie de diversification et de s\u00e9curit\u00e9 pilot\u00e9e par des g\u00e9rants de premier plan.<\/p><p>\u00a0Le m\u00e9canisme de partage du Fonds Invincible \u00c9t\u00e9 est unique : les investisseurs acceptent de plafonner leur rendement \u00e0 3 % par an, permettant ainsi de reverser le surplus (objectif d\u2019environ 5 % par an) directement \u00e0 la recherche sur la maladie.<\/p><p>L\u2019objectif affich\u00e9 est de collecter 20 millions d\u2019euros afin de g\u00e9n\u00e9rer, en rythme de croisi\u00e8re, un million d\u2019euros par an fl\u00e9ch\u00e9 vers la recherche sur la SLA.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-790ca68 e-flex e-con-boxed e-con e-parent\" data-id=\"790ca68\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-09b16ba elementor-widget elementor-widget-heading\" data-id=\"09b16ba\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Un choix en ligne directe avec la vocation historique de notre Fonds de dotation autour de la sant\u00e9 et de la solidarit\u00e9<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-02ef9ae e-flex e-con-boxed e-con e-parent\" data-id=\"02ef9ae\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3d61c26 elementor-widget elementor-widget-text-editor\" data-id=\"3d61c26\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Notre souscription au Fonds Invincible Et\u00e9 s\u2019inscrit pleinement dans la vocation historique de notre Fonds de dotation, qui r\u00e9alise chaque ann\u00e9e des placements dont les revenus financent ses missions d\u2019int\u00e9r\u00eat g\u00e9n\u00e9ral en faveur de l\u2019innovation sant\u00e9.<\/p><p>La souscription au Fonds Invincible \u00c9t\u00e9 a \u00e9t\u00e9 approuv\u00e9e \u00e0 l\u2019unanimit\u00e9 par notre Conseil d\u2019administration, convaincu de la pertinence de cette d\u00e9marche \u00e0 la fois solidaire et innovante. Une partie du rendement de cet investissement sera directement affect\u00e9e \u00e0 la lutte contre la maladie de Charcot, en compl\u00e9ment de notre action aupr\u00e8s des structures que nous accompagnons via nos appels \u00e0 projets.<\/p><p>Nous sommes extr\u00eamement honor\u00e9s de rejoindre Olivier Goy et ses partenaires dans ce combat, et les remercions vivement pour leur engagement et leur exemplarit\u00e9.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-24d5763 e-flex e-con-boxed e-con e-parent\" data-id=\"24d5763\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f72d73d elementor-widget elementor-widget-heading\" data-id=\"f72d73d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Transparence et responsabilit\u00e9<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a54272e e-flex e-con-boxed e-con e-parent\" data-id=\"a54272e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7252f84 elementor-widget elementor-widget-text-editor\" data-id=\"7252f84\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Nous rappelons que tout investissement dans ce type de fonds comporte un risque de perte en capital. Le portefeuille du Fonds Invincible \u00c9t\u00e9 est toutefois structur\u00e9 pour limiter les risques gr\u00e2ce \u00e0 une forte diversification et \u00e0 la s\u00e9lection de g\u00e9rants reconnus. La gestion pro bono garantit par ailleurs l\u2019absence de frais superflus, maximisant ainsi l\u2019impact social de chaque euro investi.<\/p><p>Enfin, notre fonds de dotation applique plus globalement des r\u00e8gles de dispersion dans sa strat\u00e9gie de placements afin d\u2019assurer la p\u00e9rennit\u00e9 de sa dotation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a66f7ee e-flex e-con-boxed e-con e-parent\" data-id=\"a66f7ee\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1731e98 elementor-widget elementor-widget-text-editor\" data-id=\"1731e98\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Cette souscription refl\u00e8te l\u2019engagement du Fonds de dotation mutualiste pour la sant\u00e9 et la solidarit\u00e9 en faveur<span style=\"font-style: inherit; font-weight: inherit;\">\u00a0du progr\u00e8s m\u00e9dical, dans le respect des valeurs de ses fondateurs, A\u00e9sio mutuelle et la Mutualit\u00e9 Fran\u00e7aise Is\u00e8re.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Le Fonds de dotation mutualiste pour la sant\u00e9 et la solidarit\u00e9 a le plaisir d\u2019annoncer sa souscription au Fonds Invincible \u00c9t\u00e9, un fonds innovant cr\u00e9\u00e9 pour soutenir la recherche sur la scl\u00e9rose lat\u00e9rale amyotrophique (SLA), plus connue sous le nom de maladie de Charcot.<\/p>\n","protected":false},"author":1,"featured_media":2779,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[16],"tags":[],"class_list":["post-2778","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/posts\/2778","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/comments?post=2778"}],"version-history":[{"count":16,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/posts\/2778\/revisions"}],"predecessor-version":[{"id":2795,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/posts\/2778\/revisions\/2795"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/media\/2779"}],"wp:attachment":[{"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/media?parent=2778"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/categories?post=2778"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fonds-mss.fr\/index.php\/wp-json\/wp\/v2\/tags?post=2778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}